Rocket Lab USA Inc (NASDAQ:RKLB) shares traded 1.53% higher at $19.29 on Wall Street last session.
RKLB stock price is now 81.28% away from the 50-day moving average and 212.70% away from the 200-day moving average. The market capitalization of the company currently stands at $10.55B.
On July 15, 2024, Morgan Stanley Downgraded its previous ‘Overweight’ rating to ‘Equal-Weight’ on the stock reducing its target price from $8 to quote $6, while ‘BTIG Research’ rates the stock as ‘Neutral’
In other news, Ocko Matthew, Director sold 3,366,193 shares of the company’s stock on Nov 15 ’24. The stock was sold for $61,312,849 at an average price of $18.21. Upon completion of the transaction, the Director now directly owns 1,377,943 shares in the company, valued at $26.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 14 ’24, Director Ocko Matthew sold 2,000,000 shares of the business’s stock. A total of $35,452,400 was realized by selling the stock at an average price of $17.73. This leaves the insider owning 2,351,135 shares of the company worth $45.35 million. A total of 28.76% of the company’s stock is owned by insiders.
During the past 12 months, Rocket Lab USA Inc has had a low of $3.47 and a high of $22.55. As of last week, the company has a debt-to-equity ratio of 1.12, a current ratio of 2.58, and a quick ratio of 2.16. The fifty day moving average price for RKLB is $10.378 and a two-hundred day moving average price translates $6.092225 for the stock.
The latest earnings results from Rocket Lab USA Inc (NASDAQ: RKLB) was released for 2024-09-30. The net profit margin was -51.76% and return on equity was -37.45% for RKLB. The company reported revenue of $104.81 million for the quarter, compared to $67.66 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 54.9 percent.
